Pacira Pharmaceuticals (PCRX)
NASDAQ:PCRX
Holding PCRX?
Track your performance easily

Pacira Pharmaceuticals (PCRX) Cash flow

350 Followers

Pacira Pharmaceuticals Cash Flow

PCRX's free cash flow for Q2 2024 was $51.65M. For the 2024 fiscal year, PCRX's free cash flow was decreased by $24.29M and operating cash flow was $53.24M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ 194.36M$ 154.65M$ 145.27M$ 126.71M$ 77.03M$ 70.52M
Investing Cash Flow
$ -26.71M$ 77.54M$ -225.19M$ -21.78M$ -277.61M$ -128.49M
Financing Cash Flow
$ -7.40M$ -183.03M$ -401.53M$ 380.69M$ 222.30M$ 3.67M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 683.52M$ 153.30M$ 104.14M$ 585.58M$ 99.96M$ 78.23M
Income Tax Paid Supplemental Data
$ 8.24M$ 4.37M$ 7.40M$ 3.22M$ 2.42M$ 863.00K
Interest Paid Supplemental Data
$ 13.82M$ 27.64M$ 33.30M$ 7.00M$ 7.21M$ 8.20M
Issuance Of Capital Stock
------
Issuance Of Debt
$ 137.95M-$ -78.13M$ 363.75M$ 402.50M$ 0.00
Repayment Of Debt
--$ -78.13M-$ -209.88M$ -338.00K
Free Cash Flow
$ 138.96M$ 139.49M$ 115.20M$ 80.84M$ 39.23M$ 60.36M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Pacira Pharmaceuticals Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis